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Recent structural studies suggest that GLUT1 (glucose trans-
porter 1)-mediated sugar transport is mediated by an alternat-
ing access transporter that successively presents exofacial (e2)
and endofacial (e1) substrate-binding sites. Transport studies,
however, indicate multiple, interacting (allosteric), and co-exis-
tent, exo- and endofacial GLUT1 ligand-binding sites. The pres-
ent study asks whether these contradictory conclusions result
from systematic analytical error or reveal a more fundamental
relationship between transporter structure and function. Here,
homology modeling supported the alternating access trans-
porter model for sugar transport by confirming at least four
GLUT1 conformations, the so-called outward, outward-oc-
cluded, inward-occluded, and inward GLUT1 conformations.
Results from docking analysis suggested that outward and out-
ward-occluded conformations present multiple -D-glucose
and maltose interaction sites, whereas inward-occluded and
inward conformations present only a single -D-glucose inter-
action site. Gln-282 contributed to sugar binding in all GLUT1
conformations via hydrogen bonding. Mutating Gln-282 to ala-
nine (Q282A) doubled theKm(app) for 2-deoxy-D-glucose uptake
and eliminated cis-allostery (stimulation of sugar uptake by sub-
saturating extracellularmaltose) but not trans-allostery (uptake
stimulation by subsaturating cytochalasin B). cis-Allostery
persisted, but trans-allostery was lost in an oligomerization-
deficient GLUT1 variant in which we substituted membrane
helix 9 with the equivalent GLUT3 sequence.Moreover, Q282A
eliminated cis-allostery in the oligomerization variant. These
findings reconcile contradictory conclusions from structural
and transport studies by suggesting that GLUT1 is an oligomer
of allosteric, alternating access transporters in which 1) cis-al-
lostery is mediated by intrasubunit interactions and 2) trans-
allostery requires intersubunit interactions.
Glucose plays a crucial role in mammalian energy metabo-
lism serving as a preferred metabolic substrate in brain and
exercising skeletal muscle (1). However, the molecular mecha-
nism by which glucose enters and exits cells is the subject of
considerable controversy (2). The blood–brain barrier and glial
and erythrocyte sugar transport are mediated by the transport
protein GLUT1 (3). Recent structural studies suggest that
GLUT1-mediated sugar transport is mediated by a carrier that
alternately presents exofacial (e2) and endofacial (e1) substrate-
binding sites (4–8). Transport studies, on the other hand, dem-
onstrate multiple, interacting, co-existent exo- and endofacial
ligand-binding sites (9–16) and e1 ligand-induced sugar occlu-
sion within GLUT1 (17). The present study asks whether these
apparently contradictory conclusions are mutually exclusive
and thus indicative of some form of systematic error in analysis
or, rather, are revealing of a more fundamental relationship
between transporter structure and function.
GLUT1 comprises 492 amino acids, is amember of themajor
facilitator superfamily (MFS)2 of proteins and shares the com-
monMFS fold (18, 19) of 12 transmembrane domains, cytoplas-
mic N and C termini and a long, partially structured intracellu-
lar loop connecting membrane spanning helices 6 and 7 (20).
GLUT1 has been crystalized in an inward open (e1 or endofa-
cial) conformation (6). Additional members of the MFS family
have been crystalized in outward open (e2 or exofacial) and
outward (e2o) and inward (e1o) partially occluded conforma-
tions. These members include human GLUT3 (e2, e2o (5)),
GLUT5 (e1, e2 (4)), and the bacterial xylose transporter XylE
(e1, e1o, e2o (7, 21)). Each structure supports the hypothesis
that the sugar translocation pathway consists of eight
amphipathic, membrane spanning -helices (H1, H2, H4, H5,
H7, H8, H10, andH11) coordinated by a scaffold of four hydro-
phobic -helices (H3, H6, H9, and H12). The N- and C-termi-
nal membrane-spanning -helices share a similar topology and
are related by a 2-fold symmetry (22).
Two competing hypotheses have been presented to explain
glucose transporter behavior: the simple, alternating access
carrier that sequentially presents mutually exclusive exofacial
and endofacial substrate-binding sites (18, 19) or the fixed-site
transporter with co-existent exofacial and endofacial sugar-
binding sites (9, 23). Initial studies using purified GLUT1 sug-
gested that exofacial and endofacial inhibitors bind at mutually
exclusive binding sites, thereby supporting the simple carrier
model (24, 25). Erythrocyte sugar transport and ligand-binding
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studies (13–16) and studies using nonreduced, purified trans-
porter (15, 16) suggest GLUT1 behaves like a fixed-site trans-
porter with interacting, cooperative binding sites.
Cell membrane resident GLUT1 forms noncovalent
homodimers and tetramers (26–29). Purified, nonreduced
GLUT1 forms a mixture of dimeric and tetrameric species,
whereas reduced purified GLUT1 is largely dimeric. GLUT1
and GLUT3 co-expressed in the same cells do not form hetero-
complexes (29, 30), but substitution of GLUT3 membrane
spanning -helix 9 (H9) into GLUT1 shifts the GLUT1 popu-
lation from a tetrameric/dimeric mixture with high transport
capacity to a dimeric population with reduced transport capac-
ity, suggesting that H9 is involved in GLUT1 oligomerization.
Conversely, substitution of GLUT1 H9 into GLUT3 converts
GLUT3 into a tetramer and increases its transport capacity to
GLUT1 levels, confirming the pivotal role of H9 in determining
GLUT quaternary structure and catalytic function (29).
Ligand-binding studies with nonreduced and reduced
GLUT1 provide further insights into the subunit organization
of the transport complex (27). The sugar transport inhibitor
cytochalasin B (CB) and intracellular sugar compete for binding
at the GLUT1 endofacial sugar-binding site (31). Purified tetra-
meric GLUT1 binds 0.5 mol CB/mol GLUT1, whereas purified
dimeric GLUT1 binds one mol CB/mol GLUT1 (27). This con-
tradiction is explained by the suggestion (28) that each subunit
of tetramericGLUT1 undergoes the e2º e1 catalytic cycle, but
at any instant two subunits must present the e1 conformation
and two must adopt the e2 conformation. In dimeric GLUT1,
each subunit is functionally unconstrained by its neighbor
and free to adopt either the e1 or e2 conformation. Thus, both
subunits of dimeric GLUT1 bind CB when [CB] is saturating.
This suggestion is reinforced by demonstrations of func-
tional coupling between GLUT1 ligand- and substrate-binding
sites. trans-Allostery is observed when low concentrations of
GLUT1 endofacial site inhibitors (e.g. forskolin or CB) increase
the affinity of the external site for transported sugar (12). As
inhibitor concentration is further increased, transport is inhib-
ited. Exofacial cis-allostery is observedwhen extracellularmalt-
ose (a nontransportable disaccharide that binds at the exofacial
sugar-binding site), stimulates sugar uptake at lowmaltose con-
centrations but inhibits uptake as its concentration is raised
(13). Endofacial cis-allostery is seen when endofacial ligand
binding (e.g. forskolin) increases the affinity of GLUT1 for a
second e1 ligand (e.g. CB) (11, 12). These findings suggest that
GLUT1 presents multiple, co-existent endo- and exofacial
ligand-binding sites and/or that oligomerization promotes sub-
unit cooperativity.
This study interrogates crystal and homology-modeled
GLUT1 structures to ask whether GLUT1 can present multiple
substrate and ligand interaction sites. Then using insights
gained from this analysis, wemutagenizeGLUT1 to examine its
impact on cis- and trans-allostery. We conclude that exofacial
cis-allostery is an intramolecular phenomenon resulting from
cross-talk betweenmultiple, co-existent ligand interaction sites
present in the exofacial cavity of each GLUT1 protein, whereas
trans-allostery and endofacial cis-allostery require ligand-in-
duced subunit–subunit interactions.
Results
Homology-modeled GLUT1 structures
GLUT1 and GLUT3 structures have been described previ-
ously (5, 6). The current study presents and interrogates three
homology-modeled GLUT1 structures—the so-called out-
ward, outward-occluded, and inward-occluded conformations
of GLUT1, plus the experimentally derived inward conforma-
tion of GLUT1 (ProteinData Bank code 4PYP (6); Fig. 1). These
conformations present a striking physical correspondence to
the proposed kinetic intermediates in the alternating access
carrier catalytic cycle named e2, e2o, e1o, and e1 (1, 32, 33),
argue strongly for sugar movements through a central translo-
cation pore, and are henceforth termed GLUT1-e2, GLUT1-
e2o, GLUT1-e1o, and GLUT1-e1.
Docking analysis of GLUT1–substrate interactions
Docking analysis first requires the location of GLUT1 pock-
ets of sufficient size to permit ligand entry and coordination.
Cavity analysis of all four homology-modeled GLUT1 confor-
mations suggests the existence of a translocation pore that tran-
sitions from one contiguous with the interstitium but excluded
from cytosol in GLUT1-e2 through intermediate, occluded
cavity forms in GLUT1-e2o and GLUT1-e1o to a cavity contig-
uous with the cytosol but excluded from the interstitium in
GLUT1-e1 (Fig. 1). Translocation pore volume increases in the
occluded state. Computed cavity volumes (Fig. 1) are GLUT1-
e2  2,850.8 Å3, GLUT1-e2o  4,397.5 Å3, GLUT1-e1o 
3,029.4 Å3, and GLUT1-e1  2,845.9 Å3. For comparison, the
molecular volume of -D-glucose (-D-Glc) based on its self-
diffusion coefficient is 433Å3 (34). Loop 6-7was not included in
cavity calculations for the GLUT1-e1 conformation. The side
chains of several residues line the cavities in all four conforma-
tions (Fig. 1C).
Glide software was developed to optimize ligand docking to
rigid protein structures using co-crystallized ligand–protein
complexes as comparative standards (35, 36). Glide scores for
computed ligand/protein pairs are useful for selecting the best
docked poses but can under- or overestimateG for binding by
2 kcal/mol (30-fold) (37).
Transport studies show that -D-Glc binding at the GLUT1
exofacial sugar-binding site involves H-bonding to pyranose
ring C1, C3, and C4 oxygens (38, 39). Similarly, ligand binding
at the endofacial sugar-binding site involves H-bonding with
OHgroups at C3 andC4 in the pyranose ring and is inhibited by
bulky substitutions at C6 (39). Docking analysis of -D-Glc
interactions with GLUT1-e2, GLUT1-e2o, GLUT1-e1o, and
GLUT1-e1 conformations is shown in Fig. 2 (A and B). The
illustrated interactions conform to the aforementioned ste-
reospecificity of GLUT1-ligand binding. Gln-282 is the one res-
idue whose side chain interacts with -D-Glc in all four GLUT1
conformations. Fig. 2C shows the relative positions of -D-Glc
in the XylE-e2o--D-Glc co-crystal structure (7) and of-D-Glc
docked to the homology-modeled GLUT1-e2o structure fol-
lowing alignment of the two protein structures. The agreement
is excellent and exceeds the resolution (2.9 Å) of the XyleE-e2o
structure.
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Additional glucose interaction sites
-D-Glc docking to GLUT1-e2 reveals additional potential
interaction sites, which we call intermediate and peripheral
sites (Fig. 3A). The intermediate site persists inGLUT1-e2o but
not in e1o and e1, suggesting that an extra sugar (in addition to
the core or transported sugar) is excluded in e1o and e1 states.
If occupancy of the intermediate site modifies GLUT1 catalytic
behavior, this could explain how extracellular sugar allosteri-
cally modulates sugar uptake. How it affects exit is more diffi-
cult to explain (12, 13). -D-Glc docking to GLUT1-e1o and
GLUT1-e1 (Fig. 3, C and D) suggests that each conformation
presents a single interaction envelope. This precludes simulta-
neous occupancy of endofacial conformations by two intracel-
lular sugars.
Interpretation of Km(app) for transport is model-dependent
and includes both binding and translocation rate constants
(33). Glide scores for -D-Glc interaction at these sites range
from4.9 to6 kcal/mol, suggestingKd(app) for -D-Glc bind-
ing of 18–135 M. Kd(app) for -D-Glc binding to GLUT1 is 0.5
mM (14). Computed Kd(app) for xylose docking to each of the
eight known XylE structures ranges from 4 to 90 M (2), yet
Kd(app) for xylose binding to XylE is 0.4 mM (7).
Docking analysis of GLUT1–inhibitor interactions
Maltose and CB are nontransported inhibitors of GLUT1-
mediated sugar transport acting at exofacial and endofacial
sites, respectively (15). Molecular docking of -maltose to
GLUT1-e2 suggests two maltose interaction domains: 1) the
Figure 1. Homology-modeled GLUT1 conformations. A, GLUT1 is shown in cartoon representation normal to the bilayer plane (horizontal orange lines).
Membrane spanning-helices (2, 3, 4, 7, 11, and 12) are indicated, and the locations of the interstitium and cytoplasm are highlighted. Four conformations are
depicted: exofacial (GLUT1-e2), exofacial-occluded (GLUT1-e2o), endofacial-occluded (GLUT1-e1o), and endofacial (GLUT1-e1). B, a second depiction of
GLUT1-e1 is shown along the bilayer normal from the cytoplasmic side. Membrane spanning -helices (noted by numbers 1–12) are indicated. C, representa-
tion of ligand-interaction cavities present in all four GLUT1 conformations shown normal to the bilayer plane. N- (N-Term) and C-terminal (C-Term) halves
(helices 1–6 and 7–12, respectively, shown in gray in cartoon representation) of each conformation are indicated. Solvent-exposed residues in the ligand
interaction cavities of each conformation are shown as surfacemaps colored cyan. Residues common to all four cavities are shown as surfacemaps colored red
and include: N-terminal residues Gly-26 and Thr-30 (of helix 1) and Gln-161, Ile-164, Val-165, and Ile-168 (of helix 5) and C-terminal residues Gln-282, Gln-283,
Ile-287, Asn-288, Phe-291, and Tyr-292 (of helix 7); Asn-317 (of helix 8); Phe-379 and Trp-388 (of helix 10); and Asn-411, Trp-412, and Asn415 (of helix 11).
Determinants of GLUT1 allostery
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core -D-Glc site and 2) an outer location comprising periph-
eral and intermediate -D-Glc interaction sites (Fig. 4A). These
sites donot sterically clash, suggesting thatGLUT1-e2 can form
a complex with two maltose molecules. GLUT1-e2o can also
accommodate a core -D-Glc or core -maltose plus an outer
-maltose (Fig. 4B). Glide scores for maltose interaction with
core and outer sites range from 6.1 to 3.4 kcal/mol corre-
sponding to Kd(app) 15 M to 2 mM. Maltose stimulates then
inhibits GLUT1-mediated sugar uptake with K0.5 values of 32
M and 3.2 mM, respectively (13), indicating close agreement
betweenGlide scores andKd(app) when the interfering exofacial
ligand is nontransportable.
Docking analysis of CB-GLUT1-e1 interactions suggests
two possible orientations for CB coordination (Fig. 5). Each
sterically clashes with the core GLUT1-e1 -D-Glc interac-
tion envelope (Fig. 5), thus explaining competition between
CB and -D-Glc for binding. Glide scores for CB interaction
with GLUT1-e1 are consistent with Kd(app) for CB binding of
0.1 to 5 M. Kd(app) for CB binding to GLUT1 ranges from
150 to 180 nM (24, 40).
Effects of inhibitors on sugar transport
The predicted involvement of Gln-282 in -D-Glc coordina-
tion by all GLUT1 conformations suggests that this residue
plays a central role in sugar transport. We therefore
mutagenized Gln-282 to alanine. The concentration depen-
dence of the initial rate of 2-deoxy-D-glucose (2DG) uptake by
HEK293 cells expressing wtGLUT1 or GLUT1 containing
the Q282A mutation (GLUT1Q282A) is well-approximated by
Michaelis–Menten kinetics (Fig. 6A). Vmax for net 2DG uptake
Figure 2.-D-Glc docking to homology-modeledGLUT1 conformations. A, each GLUT1 conformation is shown complexedwith-D-Glc (shown in red as a
space-filling representation). The location of GLUT1 Gln-282 is shown in cyan in space-filling format. Conformation nomenclature is indicated beneath each
structure where-D-Glc is represented by the letter S, and occluded-D-Glc (by convention) is represented by the letter S in parentheses. B,-D-Glc docking to
GLUT1 conformations in which Glc is shown as a 2D structure, coordinating GLUT1 residues are shown as circles and are colored according to their properties:
green, hydrophobic, cyan, polar; red, negative. The GLUT1 backbone is shown as ribbons, solvent-exposed regions of -D-Glc are indicated by gray-shaded
circles, and H-bonds shared between amino acid side chain amines, carbonyls, or hydroxyls with-D-Glc and their directionality are represented as red arrows.
C, alignment of XylE-e2o containing a co-crystallized -D-Glc (Protein Data Bank code 4GBZ (7); XyleE with homology-modeled GLUT1-e2o containing its
docked-D-Glc (GLUT1-e2o(S)). Bothproteins are hidden to show theproximity of co-crystallized anddocked sugars. XylE-bound-D-Glc lacks hydrogens, and
its carbons are colored yellow. GLUT1-bound -D-Glc carbons are colored cyan. The black scale bar indicates the length of a single C–C bond (0.154 Å).
Determinants of GLUT1 allostery
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(wtGLUT1  3.18  1012  0.25  1012 mol/g protein/
min) is unaffected by the Q282A mutation (Vmax  3.38 
1012 0.28 1012 mol/g protein/min). However, Km(app)
for net sugar uptake by wtGLUT1 (0.89 0.18 mM) is doubled
in GLUT1Q282A (Km(app)  1.59  0.28 mM). Cell-surface
GLUT1 biotinylation studies confirm that HEK293 cells
express similar levels of wtGLUT1 and GLUT1Q282A (Fig. 6B).
Replicate analysis (n 5; Fig. 6C) reveals that Km(app) is signif-
icantly increased inGLUT1Q282A (paired t test, p 0.0046), but
Vmax is unchanged (p 0.2036).
Figure 3. GLUT1 presents additional -D-Glc binding sites. GLUT1 is oriented as in Fig. 1A. A, -D-Glc (in red) docking to GLUT1-e2 reveals three potential sites
termed peripheral, intermediate, and core. Computed glide scores (GSs) for ligand binding are as follows: peripheral GS5.1 kcal/mol, intermediate GS5.1
kcal/mol, coreGS4.9 kcal/mol.B,-D-Glc (in red) docking toGLUT1-e2o reveals twopotential sites termedperipheral and core. ComputedGSs for ligandbinding
areas follows:peripheralGS6.0kcal/mol, coreGS5.8kcal/mol.C,-D-Glc (in red)dockingtoGLUT1-e1orevealsonepotential sitewithcomputedGSfor ligand
binding5.1 kcal/mol.D,-D-Glc (in red) docking to GLUT1-e1. ComputedGSs for ligand binding are as follows: core 1 GS5.4 kcal/mol.
Figure 4. Maltose binding to the exofacial conformation of GLUT1.
GLUT1 is oriented as in Fig. 1A. A, -maltose binding. Maltose (a disaccharide
comprising two glucose units joined with an (134) bond) can occupy two
sites inGLUT1-e2: a site (shown in yellow) comprising the core-D-Glc site and
extending into additional space or a site (shown in green) comprising inter-
mediate andperipheral-D-Glc sites.-D-Glc is indicatedas a stick figureoccu-
pying its core site. Glide scores for maltose-binding core and intermediate
sites are6.1 and5.6 kcal/mol, respectively. B, maltose occupies two sites
in GLUT1-e2o comprising core (yellow) and peripheral (green) sites. Glide
scores for maltose binding at core and peripheral sites are 3.4 and 5.0
kcal/mol, respectively.-D-Glc is indicated as a stick figure occupying the core
site.
Figure 5. CB interaction sites in GLUT1-e1. GLUT1 is oriented as in Fig. 1A.
CB adopts two overlapping coordinations in GLUT1-e1. These are shown as
space-fillingmolecules in dark blue (CB site 1) and light blue (CB site 2). GS for
CB binding to sites 1 and 2 are7.2 and6.6 kcal/mol, respectively. Both CB
sites suggest steric hindrance with the core -D-Glc binding site (shown as a
space-filling molecule in red).
Determinants of GLUT1 allostery
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Two types of “allostery” have been described for GLUT1-
mediated sugar import. cis-Allostery is obtainedwhen extracel-
lular inhibitors (e.g.maltose) stimulate sugar uptake at low con-
centrations but inhibit uptake at higher concentrations (13).
trans-Allostery describes sugar uptake stimulation by subsatu-
rating levels of endofacial inhibitors (e.g. CB, forskolin) (12).
cis-Allostery is eliminated in GLUT1Q282A
Subsaturating extracellular maltose (10–50 M) stimulates
wtGLUT1-mediated 2DG uptake (Fig. 7A), but higher concen-
trations inhibit transport. Low concentrations of maltose are
without effect on sugar uptake byGLUT1Q282A, but higher con-
centrations inhibit transport (Fig. 7A).
trans-Allostery persists in GLUT1Q282A
CB stimulates 2DG uptake at low concentrations (0.025 M
CB) in both wtGLUT1 and GLUT1Q282A but inhibits transport
at higher concentrations (Fig. 7B).
cis- and trans-Allostery in a GLUT1-oligomerizationmutant
GLUT1 forms a mixture of homotetramers and homo-
dimers in red cell membranes and in CHO and HEK293 cells
(26, 29). GLUT1 tetramerization (but not sugar transport) is
eliminated in a GLUT1/GLUT3 chimera in which the
GLUT1 membrane-spanning helix 9 is substituted with the
GLUT3 membrane-spanning helix 9 sequence (29). We used
this tetramerization-deficient mutant (GLUT1(GLUT3-H9))
Figure 6. Sugar transport in HEK293 cells heterologously expressingwtGLUT1 or GLUT1Q282A. A, Michaelis–Menten kinetics of zero-trans 2DG uptake in
cells expressing wtGLUT1 (E) or GLUT1Q282A (F). 2DG uptake in mol/g cell protein/min is plotted versus [2DG] in mM. Each data point is the mean S.E. of
threeormoreduplicatemeasurements and is corrected for 2DGuptake inmock-transfectedcells. The curveswere computedbynonlinear regressionassuming
Michaelis–Menten uptake kinetics (Equation 1) and have the following constants: wtGLUT1 (F): Vmax 3.2 0.02 pmol/g protein/min, Km(app) 0.89 0.18
mM, R2 0.884, standard error of regression 0.31 pmol/g protein/min; GLUT1Q282A (E): Vmax 3.4 0.3 pmol/g protein/min, Km(app) 1.59 0.28 mM,
R2 0.926, standard error of regression 0.24 pmol/g protein/min. B, cell surface expression of wtGLUT1 and GLUT1Q282A in HEK293 cells. The mobility of
molecularweightmarkers is indicatedat the leftof theblotwhich showsGLUT1 levels present inbiotinylatedmembraneproteins collected fromuntransfected
(UTF), wtGLUT1-expressing (WT), and GLUT1Q282A-expressing (Q282A) HEK293 cells. C, Km(app) but not Vmax for 2DG transport is affected in GLUT1Q282A. The
results of five separate experiments are shownas scatter-dot plots for both Km(app) andVmax. The results are shownasmeans S.E. Paired t test analysis (dashed
lines indicate pairedmeasurements) indicates that Vmax is not significantly affected by the Q282Amutation (p 0.2036) but that Km(app) increases 2-fold (p
0.0046).
Determinants of GLUT1 allostery
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to ask whether cis- or trans-allostery require GLUT1
tetramerization.
Subsaturating levels of maltose stimulate both GLUT1- and
GLUT1(GLUT3-H9)-mediated 2DG uptake, whereas higher con-
centrations of maltose inhibit uptake (Fig. 8A). Introduction of
the Q282A mutation to the GLUT1(GLUT3-H9) background
eliminates sugar uptake stimulation by subsaturating [maltose]
(Fig. 8A). Although cis-allostery persists in the oligomerization-
deficient mutant, subsaturating [CB] no longer stimulates 2DG
uptake in GLUT1(GLUT3-H9)- or GLUT1(GLUT3-H9)Q282A-ex-
pressing HEK293 cells (Fig. 8B).
The effects of stimulating levels of maltose (10 and 50 M)
and CB (25 nM) on 2DG uptake in GLUT1, GLUT1Q282A,
GLUT1(GLUT3-H9), and GLUT1(GLUT3-H9)Q282A are summa-
rized in Fig. 9. Stimulation by maltose but not by CB is elimi-
nated in GLUT1Q282A. Stimulation by maltose but not by CB
persists in GLUT1(GLUT3-H9), and all stimulations are lost in
GLUT1(GLUT3-H9)Q282A.
Discussion
As more sugar transporter structures become available, the
weight of evidence supporting the alternating access trans-
porter model for sugar transport grows. Each study (4, 6, 7, 21,
22, 41) has interpreted transporter structures in the context of
this model (18, 19, 32) in which the transporter cycles between
conformations presenting either an exofacial cavity to extracel-
Figure 7. cis- and trans-Allostery in wtGLUT1 (F) and GLUT1Q282A (E). A,
cis-allostery. Concentrationdependenceofmaltosemodulationof 2DG influx
is shown. Normalized 2DG uptake (vi/vc) is plotted as a function of [maltose]
(mM) on a log scale. The curves drawn through the points (solid lines for
wtGLUT1 (F) and dashed lines for GLUT1Q282A (E)) were computed by nonlin-
ear regression using Equation 2 and have the following constants: wtGLUT1
(F), K1 0.0028, K2 0.31 mM1, K3 0.197 mM1, K4 1.62 mM2, R2
0.582, standard error of regression 0.147; GLUT1Q282A (E), K1 0.028, K2
1.83 mM1, K3 1.911 mM1, K4 1.62 mM2, R2 0.582, standard error of
regression 0.147. B, trans-allostery. Concentration dependence of CBmod-
ulation of 2DG influx is shown. Normalized 2DG uptake (vi/vc) is plotted as a
functionof [CB] (M) ona log scale. The curvesdrawn through thepoints (solid
lines forwtGLUT1 (F) and dashed lines for GLUT1Q282A (E)) were computedby
nonlinear regression using Equation 2 and have the following constants:
wtGLUT1 (F), K1 0.0041M2, K2 0.073M, K3 2 1012M, K4 1.64,
R2 0.637, standard error of regression 0.179; GLUT1Q282A (E), K1 0.0050
M2, K2 0.039 M, K3 8.3 1014 M, K4 1.495, R2 0.849, standard
error of regression 0.067.
Figure 8. cis- and trans-Allostery in a GLUT1 oligomerization-deficient
background.GLUT1(GLUT3-H9) and GLUT1(GLUT3-H9)Q282A expressed in HEK293
cells were tested for their ability to mediate cis- and trans-allostery. A, cis-
allostery. Concentration dependence of maltose modulation of 2DG influx.
Normalized 2DG uptake (vi/vc) is plotted versus [maltose] (mM) on a log scale.
The curves drawn through the points (solid lines for GLUT1(GLUT3-H9) and
dashed lines for GLUT1(GLUT3-H9)Q282A) were computed by nonlinear regres-
sion using Equation 2 and have the following constants: GLUT1(GLUT3-H9) (F),
K10.0022, K22.052mM1, K31.707mM1, K41.72mM2,R20.656,
standard error of regression  0.137; GLUT1(GLUT3-H9)Q282A (E), K1  0.081,
K2 0.63 mM1, K3 0.626 mM1, K4 1.528 mM2, R2  0.747, standard
error of regression 0.080. B, trans-allostery. Concentration dependence of
CB modulation of 2DG influx. Normalized 2DG uptake (vi/vc) is plotted versus
[CB] (M) on a log scale. The curves drawn through the points (solid lines for
GLUT1(GLUT3-H9) and dashed lines for GLUT1(GLUT3-H9)Q282A) were computed by
nonlinear regression using Equation 3 and have the following constants:
GLUT1(GLUT3-H9) (F), K1 0.984 M/s, K2 0.740 M/s, K3 0.138 M, R
2
0.963, standard error of regression  0.058; GLUT1(GLUT3-H9)Q282A (E), K1 
0.996 M/s, K2  0.711 M/s, K3  0.065 M, R2  0.904, standard error of
regression 0.093.
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lular sugars or an edofacial cavity to cytoplasmic sugars. Sugar
binding to exofacial (e2) or endofacial (e1) conformations pro-
motes gating transitions that occlude the bound sugar from the
interstitium (forming the e2o state) or from the cytoplasm
(forming the e1o state). Occlusion triggers rigid body move-
ments leading to e2o conversion to e1o and vice versa. The
trans-gate then opens, releasing bound sugar at the opposite
side of the membrane. The catalytic cycle concludes via the
reverse sequence of conformational changes with or without
bound sugar as cargo.
This interpretation of the structural data has excited criti-
cism (2, 9, 11–16) for three reasons: 1)we donot yet have crystal
structures of each GLUT conformation complexed with a
transported sugar; 2) available sugar transport data demon-
strate that GLUT1 simultaneously presents exofacial and endo-
facial ligand-binding sites; and 3) transport and ligand-binding
studies demonstrate that the transporter interacts with more
than one exofacial ligand (e.g. -D-Glc plus maltose) and more
than one endofacial ligand (e.g.CBplus forskolin) at any instant.
Ligand interaction sites
We therefore asked whether available crystal structures sup-
port the idea that e2 and e1 forms of GLUT1 can simultane-
ously bind multiple ligands in exo- or endofacial cavities.
Although a crystal structure for GLUT1-e1 is available (6), it
was necessary to model GLUT1-e2, GLUT1-e2o, and GLUT1-
e1o structures using the human GLUT3 (Protein Data Bank
code 4ZWC) structure (5) and theXylE e2-occluded and e1-oc-
cluded structures (7, 21), respectively.
Molecular docking reveals that the GLUT1-e2 exofacial cav-
ity presents three potential, nonoverlapping -D-Glc interac-
tion sites and two nonoverlapping maltose interaction sites.
-D-Glc interaction envelopes are located at peripheral, inter-
mediate, and core locations within the exofacial cavity. One
maltose interaction envelope overlaps with the core -D-Glc
interaction envelope, and the second is more peripherally
located in the exofacial cavity. Docking suggests that
GLUT1-e2 can simultaneously accommodate core-D-Glc and
peripheral maltose. These three -D-Glc sites may represent
progressive steps in -D-Glc binding or three co-existent inter-
action sites. The latter hypothesis is consistent with the obser-
vation that the transporter can bind extracellular maltose and
transported sugar simultaneously (see Ref. 13 and this study).
We next asked whether GLUT1-e1 or GLUT1-e2 simultane-
ously interact with endofacial and exofacial ligands. Molecular
docking analysis indicates that this is highly improbable.
Finally, we asked whether GLUT1-e1 interacts with more than
one endofacial ligand simultaneously. GLUT1-e1 presents a
single potential, CB interaction envelope that accommodates
CB in either of 2 possible but mutually exclusive orientations.
Both orientations sterically clash with the GLUT1-e1 -D-Glc
interaction envelope, providing a rationale for competition
between intracellular -D-Glc and CB for binding to GLUT1
(25). CB interaction envelopes also sterically clash with the for-
skolin interaction envelope,3 explaining competition between
CB and forskolin for binding to GLUT1 (11).
Amodel for allostery
cis- and trans-Allostery (sugar import stimulation at low
[inhibitor] followed by inhibition at high [inhibitor]) require
that GLUT1must bind inhibitors at least two sites. This is read-
3 O. A. Ojelabi and A. Carruthers, unpublished docking analysis.
Figure 9. Scatter plots of the effects of maltose (10 and 50M) and CB (25 nM) on 0. 1mM 2DG uptake in cells expressing GLUT1 (A), GLUT1Q282A (B),
GLUT1(GLUT3-H9) (C), and GLUT1(GLUT3-H9)Q282A (D). Normalized uptake (vi/vc) is plotted versus concentrations of maltose and CB applied during 2DG uptake
measurements. The results are shown as the averages of paired replicates (n 4) andmeans S.E. of multiple experiments (n 3). The data were examined
by unpaired t test analysis comparing the effect of treatment to no treatment (vi/vc  1 as indicated by the dashed horizontal line), and the computed
significance levels are indicated above the points for treatments resulting in p 0.05.
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ily explicable for cis-allostery (maltose-dependent) because
GLUT1-e2 presents two co-existent, exofacial maltose interac-
tion sites, and -D-Glc competes with maltose for binding at
both sites. trans-(CB-dependent) allostery is more difficult to
explain because GLUT1-e1 presents only one CB interaction
site. We therefore conclude that each GLUT1 molecule is an
alternating access transporter capable of exofacial cis-allostery
but incapable of trans-allostery when catalyzing sugar import.
How then do we explain trans-allostery?
Previous work (26, 27, 29, 42–46) demonstrates that GLUT1
forms mixtures of dimeric and tetrameric GLUT1 complexes.
When purifying RBC GLUT1, the ratio of dimeric:tetrameric
GLUT1 is affected by cellular redox status with reducing con-
ditions favoring the dimeric form (26, 27). GLUT1 cysteines
347 and 421 may form mixed disulfides under nonreducing
conditions (26, 27), and GLUT1 transmembrane helix 9 con-
tains GLUT1-specific sequence essential for tetramerization
(29). Reduced, dimeric GLUT1 presents 1 CB binding site/
GLUT1 molecule, whereas nonreduced, tetrameric GLUT1
presents only 0.5 CB binding sites/GLUT1 molecule (26, 27,
45). Extracellular reductant inhibits RBC sugar import by
80–90% (26, 27) and eliminates trans- but not cis-allostery (12).
The molecular mechanisms by which Gln-282 and mem-
brane spanning helix 9 (TM9) promote cis- and trans-allostery,
respectively, are unknown. However, our observations support
the followingmodel. Dimeric GLUT1 comprises two physically
associated but functionally independent GLUT1 molecules.
Each subunit displays cis- but not trans-allostery in net sugar
uptake and binds 1 molecule of CB, and because transport is
rate-limited by conformational changes between unliganded e1
and e2 states (relaxation (32)), transport is characterized by a
low kcat. Tetrameric GLUT1 comprises a noncovalent dimer of
two associated and functionally coupled GLUT1 molecules.
Intradimer subunit interactions produce a functional, anti-par-
allel arrangement of subunits. If one GLUT1molecule presents
an e2 conformation, its cognate partner in the dimermust pres-
ent an e1 conformation and vice versa. When an e2 subunit of
any dimer interacts with extracellular sugar to undergo the
eS23 eS1 conformational change, its cognate partner under-
goes the e1 3 e2 conformational change thereby coupling
transport via one subunit to the regeneration of an e2 confor-
mation in the cognate subunit, bypassing slow relaxation, and
accelerating net sugar transport. Because only two subunits in
tetrameric GLUT1 can present the e1 conformation, the stoi-
chiometry of CB binding is 0.5 mol CB/mol GLUT1. Each sub-
unit functions as an allosteric alternating access transporter in
importmode. trans-Allostery in sugar import obtainswhen one
e1 subunit interacts with high affinity with an endofacial ligand
(e.g. CB or forskolin). The dimer presenting this liganded e1
conformation is locked in an inhibited state, but its occupancy
is communicated to the adjacent dimer, increasing the affinity
of that dimer for extracellular -D-Glc or kcat for transport. As
the endofacial ligand concentration is raised, the remaining free
e1 subunit in the adjacent dimer is occupied, and both dimers
are inhibited. Endofacial cis-allostery obtains when the affinity
of an unliganded e1 subunit in one dimer is increased by occu-
pancy of the e1 subunit of the adjacent dimer.
In conclusion, GLUT1 functions as an oligomer of allosteric,
alternating access transporters. cis- and trans-Allostery require
intra- and intersubunit interactions, respectively. Each GLUT1
molecule appears to present a core, catalytic sugar-binding site.
The exofacial conformer of GLUT1 presents at least one and
possibly two additional sugar interaction sites whose occu-
pancy allosterically affects transport via the catalytic site. trans-
Allostery requires at least one subunit to bind an endofacial
ligand and one to bind an extracellular, imported sugar. Pre-
venting GLUT1–GLUT1 interactions in an oligomerization-
deficient mutant eliminates trans- but not cis-allostery.
Mutating Gln-282 to alanine eliminates cis-allostery but not
trans-allostery.
Experimental procedures
Reagents
[3H]2DG was purchased from American Radiolabeled
Chemicals. Unlabeled 2DG, maltose, CB, and phloretin were
purchased from Sigma–Aldrich. All primers were purchased
from Integrated DNA Technologies. Herculase polymerase,
XL1-BlueCompetent cells, andQuikChangemultisite-directed
mutagenesis kits were obtained from Agilent Technologies.
SuperSignal PicoWest, NeutrAvidin Gel, micro-BCA kits, spin
columns, and EZ-Link Sulfo-NHS-ss-Biotin were from Pierce.
Solutions
PBS comprised 140mMNaCl, 10mMNa2HPO4, 3.4 mMKCl,
1.84 mM KH2PO4, pH 7.3. Solubilization buffer comprised PBS
medium with 0.5% Triton X-100 and 5 mM MgCl2. Stop solu-
tion comprised PBS-Mg medium plus CB (CB; 10 M) and
phloretin (100 M). Sample buffer contained 0.125 M Tris-HCl
(pH 6.8), 4% SDS, 20% glycerol, and 50 mM DTT. Transfer
buffer comprised 12 mM Tris Base, 96 mM glycine, 20%
methanol.
Antibodies
A custom-made (New England Peptide) affinity-purified
goat polyclonal antibody (C-Ab) raised against a peptide corre-
sponding to GLUT4 C-terminal residues 498–509 was used at
1:10,000dilution (47).Horseradishperoxidase-conjugateddonkey
anti-goat secondary antibody (Jackson ImmunoResearch) was
used at 1:50,000 dilution.
Tissue culture
HEK293 cells were maintained in DMEM supplemented
with 10% fetal bovine serum, 100 units/ml penicillin, and 100
g/ml streptomycin in a 37 °C humidified 5%CO2 incubator as
described previously (48). All of the experiments were per-
formed with confluent cells. The plates were subcultured into
12-well plates at a ratio of 1:2–1:5 2–4 days prior to transfec-
tions. Passages 4–20 were used for all experiments.
Mutagenesis
GLUT1-encoding cDNA was inserted into the EcoRV–NotI
restriction sites of PCDNA 3.1(	). As described previously
(29), the C-terminal 13 amino acids of this GLUT1 construct
are substituted using the C-terminal 13 amino acids of GLUT4
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to facilitate detection of heterologously expressed GLUT1
against a low level background expression of endogenous
GLUT1. Mutagenesis was as described previously (49) using
QuikChange multisite-directed mutagenesis kits and was veri-
fied by sequencing. The GLUT1 construct in which H9 is sub-
stituted with GLUT3 H9 sequence was described previously
(29).
Transient transfection
The cells (70–90% confluence) were transfected with 2 g
(12-well plates) or 5 g of DNA/well (6-well plates). Transfec-
tions were performed 36–48 h prior to analysis of sugar uptake
or protein expression. Sugar uptake and cell-surface biotinyla-
tion measurements were performed in tandem. Heterologous
expression of GLUT1, GLUT3, GLUT1/GLUT3, and GLUT4
chimeras and their associatedmutations inHEK293 cells was as
described previously (29, 49).
Cell-surface expressionmeasurements
Three days post-transfection, 6-well plates of HEK cells were
washed twice with ice-cold PBS and incubated on ice with ice-
cold PBS containing 5 mM EZ-Link Sulfo-NHS-ss-Biotin for 30
min with gentle rocking. The reactions were quenched by
adjusting each well to 12.5 mM Trizma (Tris base). The cells
were harvested and resuspended in biotin lysis buffer, and
lysates were bound to NeutrAvidin gel in spin columns accord-
ing to kit instructions. Protein was eluted from spin columns
using reductant, and the eluate protein concentration was
determined spectrophotometrically. Normalized loads were
analyzed by Western blotting.
Western blotting
GLUT1 expression in whole cell lysates and cell surface
expression by biotinylation were analyzed by Western blot as
previously described (50). Total and isolated Biotinylated pro-
teins were normalized for total protein concentration by BCA
and resolved by SDS-PAGE on a 10% NuPage gel in NuPage
running buffer. The gels were transferred onto PVDF mem-
branes blocked with 3% bovine serum albumin in PBS-T,
probed with primary antibody overnight at 4 °C, probed with
secondary antibody for 1 h at room temperature, and developed
using SuperSignal Pico West Chemiluminescent substrate.
Blots were imaged on a FujiFilm LAS-3000, and relative band
densities were quantitated using ImageJ32 software.
2-Deoxy-D-glucose uptake
2DG uptake was measured as described previously (29).
Briefly, 36–48 h post-transfection, confluent 12-well plates of
HEK-293 cells were serum- and glucose-starved for 2 h at 37 °C
in FBS and penicillin/streptomycin-free DMEM lacking glu-
cose. The cells were washed with 1.0 ml of DPBS-Mg at 37 °C
for 15 min and then exposed to 0.4 ml of [3H]2DG uptake solu-
tion at various 2DG concentrations (0.1–20 mM) for 5 min at
37 °C. Uptake was stopped by the addition of 1 ml of ice-cold
stop solution. The cells were washed twice with ice-cold stop
solution and lysed with Triton lysis buffer. Total protein con-
tent was analyzed in duplicate by BCA. Each sample was
counted in duplicate by liquid scintillation spectrometry. Each
mutant was analyzed in triplicate on at least three separate
occasions. cis- and trans-allostery experiments measured 0.1
mM 2DG uptake in cells exposed to [maltose] or [CB],
respectively.
Homologymodeling
We modeled GLUT1 e2, e2-occluded, and e1-occluded
structures respectively using the human GLUT3 (Protein Data
Bank code 4ZWC) structure (5) and theXylE e2-occluded (Pro-
tein Data Bank code 4GBZ) and e1-occluded (Protein Data
Bank code 4JA3) structures (7, 21). We removed ligands and
used chain A as the template for each modeled structure.
Sequence alignments were generated using ClustalX. Homol-
ogy models were built using Modeler 9.9 and analyzed using
PROCHECK. The GLUT1 e1 structure (Protein Data Bank
code 4PYP (6)) was used directly.
Cavity analysis
Cavities for ligand docking were calculated using the CastP
server (http://sts.bioe.uic.edu/castp/) (51),4 and the grid was
centered on the residues forming the cavity.
Stochastic docking
-D-Glucose, maltose and CB structures were obtained from
ZINC (http://zinc.docking.org; Ref. 52).4 The WZB117 struc-
ture was generated using the 3D structure generator Corina
from Molecular Networks GmbH (http://www.molecular-
networks.com).4 Docking was performed using the Schro-
dinger software suite. No restraints were used during the dock-
ing. The protein structure was preprocessed with the Protein
Preparation Wizard, bond orders were assigned, hydrogens
were added, and the H-bond network was optimized. The sys-
tem was energy-minimized using the OPLS 2005 force field.
Ligand structures were prepared with the LigPrep module, and
the pKa of the ligands was calculated using the Epik module.
Computational docking was performed by the GLIDE module
in standard-precision mode and default values for grid genera-
tion. Grids were mapped using CastP cavity analysis and ligand
positions from the original crystal structures.
Data analysis
Data analysis was undertaken using GraphPad Prism (ver-
sion 7.0c; GraphPad Software, Inc.). Curve fitting was by non-
linear regression using the following equations. For concentra-
tion dependence of 2-deoxy-D-glucose uptake,
v21 
Vmax
S
Kmapp 
S
(Eq. 1)
where [S] is [2DG], and Vmax and Km(app) have the usual mean-
ing. Exofacial cis-allostery and endofacial trans-allostery are
expressed as normalized 2DG uptake, which is described by the
following,
v i
vc

K1 
IK2 
I
K1 
IK3 
IK4
(Eq. 2)
4 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
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where vi/vc is uptake in the presence of inhibitor divided by
uptake in the absence of inhibitor, [I] is the concentration of cis-
or trans-inhibitor, and interpretation of constants is model-de-
pendent and described by Lloyd et al.5 When simple saturable
inhibition of transport is observed, normalized 2DG uptake is
described by Equation 3,
v i
vc
 K1
K2
I
K3 
I
(Eq. 3)
where vi/vc is uptake in the presence of inhibitor divided by
uptake in the absence of inhibitor,K1 is uptake in the absence of
inhibitor I, K2 is the difference between K1 and uptake in the
presence of saturating [I], and K3 is Ki(app) for uptake inhibi-
tion by I.
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